Medical Care
Global Small Interfering RNA (siRNA) Market Research Report 2025
- May 12, 25
- ID: 235242
- Pages: 86
- Figures: 88
- Views: 8
The global market for Small Interfering RNA (siRNA) was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Small interfering RNA (siRNA) is a kind of endogenous single stranded RNA with regulatory function found in Eukaryote, generally 18-25nt. It can cause the degradation of target mRNA and inhibit its translation through specific binding with target mRNA, so as to regulate the post transcriptional expression of genes. Recent studies have shown that miRNAs are involved in various regulatory pathways, including development, viral defense, hematopoietic processes, organ formation, cell proliferation and apoptosis, and fat metabolism. DIA-UP"s advanced chemical synthesis technology can provide customers with products such as miRNA inhibitors, miRNA mimetics, miRNA negative controls, Agomir, and Antagonir.
North American market for Small Interfering RNA (siRNA) is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Small Interfering RNA (siRNA) is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Small Interfering RNA (siRNA) in Cancer is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Small Interfering RNA (siRNA) include Agilent Technologies, Merck KGaA, QIAGEN (Exiqon), NanoString Technologies, Inc., Dharmacon (Horizon Discovery Group), Synlogic, GeneCopoeia, Inc., New England Biolabs, Quantabio, NanoString Technologies, Inc., etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Small Interfering RNA (siRNA), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Small Interfering RNA (siRNA).
The Small Interfering RNA (siRNA) market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Small Interfering RNA (siRNA) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Small Interfering RNA (siRNA) companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Agilent Technologies
Merck KGaA
QIAGEN (Exiqon)
NanoString Technologies, Inc.
Dharmacon (Horizon Discovery Group)
Synlogic
GeneCopoeia, Inc.
New England Biolabs
Quantabio
NanoString Technologies, Inc.
BioGenex
SeqMatic LLC
Segment by Type
General Chemical Synthesis of siRNA
Sterol Modified Chemical Synthesis of siRNA
Segment by Application
Cancer
Infectious Diseases
Immunological Disorder
Cardiovascular Disease
Neurological Disease
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Small Interfering RNA (siRNA) company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Small interfering RNA (siRNA) is a kind of endogenous single stranded RNA with regulatory function found in Eukaryote, generally 18-25nt. It can cause the degradation of target mRNA and inhibit its translation through specific binding with target mRNA, so as to regulate the post transcriptional expression of genes. Recent studies have shown that miRNAs are involved in various regulatory pathways, including development, viral defense, hematopoietic processes, organ formation, cell proliferation and apoptosis, and fat metabolism. DIA-UP"s advanced chemical synthesis technology can provide customers with products such as miRNA inhibitors, miRNA mimetics, miRNA negative controls, Agomir, and Antagonir.
North American market for Small Interfering RNA (siRNA) is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Small Interfering RNA (siRNA) is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Small Interfering RNA (siRNA) in Cancer is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Small Interfering RNA (siRNA) include Agilent Technologies, Merck KGaA, QIAGEN (Exiqon), NanoString Technologies, Inc., Dharmacon (Horizon Discovery Group), Synlogic, GeneCopoeia, Inc., New England Biolabs, Quantabio, NanoString Technologies, Inc., etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Small Interfering RNA (siRNA), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Small Interfering RNA (siRNA).
The Small Interfering RNA (siRNA) market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Small Interfering RNA (siRNA) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Small Interfering RNA (siRNA) companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Agilent Technologies
Merck KGaA
QIAGEN (Exiqon)
NanoString Technologies, Inc.
Dharmacon (Horizon Discovery Group)
Synlogic
GeneCopoeia, Inc.
New England Biolabs
Quantabio
NanoString Technologies, Inc.
BioGenex
SeqMatic LLC
Segment by Type
General Chemical Synthesis of siRNA
Sterol Modified Chemical Synthesis of siRNA
Segment by Application
Cancer
Infectious Diseases
Immunological Disorder
Cardiovascular Disease
Neurological Disease
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Small Interfering RNA (siRNA) company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Small Interfering RNA (siRNA) Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 General Chemical Synthesis of siRNA
1.2.3 Sterol Modified Chemical Synthesis of siRNA
1.3 Market by Application
1.3.1 Global Small Interfering RNA (siRNA) Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Cancer
1.3.3 Infectious Diseases
1.3.4 Immunological Disorder
1.3.5 Cardiovascular Disease
1.3.6 Neurological Disease
1.3.7 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Small Interfering RNA (siRNA) Market Perspective (2020-2031)
2.2 Global Small Interfering RNA (siRNA) Growth Trends by Region
2.2.1 Global Small Interfering RNA (siRNA) Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Small Interfering RNA (siRNA) Historic Market Size by Region (2020-2025)
2.2.3 Small Interfering RNA (siRNA) Forecasted Market Size by Region (2026-2031)
2.3 Small Interfering RNA (siRNA) Market Dynamics
2.3.1 Small Interfering RNA (siRNA) Industry Trends
2.3.2 Small Interfering RNA (siRNA) Market Drivers
2.3.3 Small Interfering RNA (siRNA) Market Challenges
2.3.4 Small Interfering RNA (siRNA) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Small Interfering RNA (siRNA) Players by Revenue
3.1.1 Global Top Small Interfering RNA (siRNA) Players by Revenue (2020-2025)
3.1.2 Global Small Interfering RNA (siRNA) Revenue Market Share by Players (2020-2025)
3.2 Global Small Interfering RNA (siRNA) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Small Interfering RNA (siRNA) Revenue
3.4 Global Small Interfering RNA (siRNA) Market Concentration Ratio
3.4.1 Global Small Interfering RNA (siRNA) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Small Interfering RNA (siRNA) Revenue in 2024
3.5 Global Key Players of Small Interfering RNA (siRNA) Head office and Area Served
3.6 Global Key Players of Small Interfering RNA (siRNA), Product and Application
3.7 Global Key Players of Small Interfering RNA (siRNA), Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Small Interfering RNA (siRNA) Breakdown Data by Type
4.1 Global Small Interfering RNA (siRNA) Historic Market Size by Type (2020-2025)
4.2 Global Small Interfering RNA (siRNA) Forecasted Market Size by Type (2026-2031)
5 Small Interfering RNA (siRNA) Breakdown Data by Application
5.1 Global Small Interfering RNA (siRNA) Historic Market Size by Application (2020-2025)
5.2 Global Small Interfering RNA (siRNA) Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Small Interfering RNA (siRNA) Market Size (2020-2031)
6.2 North America Small Interfering RNA (siRNA) Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Small Interfering RNA (siRNA) Market Size by Country (2020-2025)
6.4 North America Small Interfering RNA (siRNA) Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Small Interfering RNA (siRNA) Market Size (2020-2031)
7.2 Europe Small Interfering RNA (siRNA) Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Small Interfering RNA (siRNA) Market Size by Country (2020-2025)
7.4 Europe Small Interfering RNA (siRNA) Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Small Interfering RNA (siRNA) Market Size (2020-2031)
8.2 Asia-Pacific Small Interfering RNA (siRNA) Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Small Interfering RNA (siRNA) Market Size by Region (2020-2025)
8.4 Asia-Pacific Small Interfering RNA (siRNA) Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Small Interfering RNA (siRNA) Market Size (2020-2031)
9.2 Latin America Small Interfering RNA (siRNA) Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Small Interfering RNA (siRNA) Market Size by Country (2020-2025)
9.4 Latin America Small Interfering RNA (siRNA) Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Small Interfering RNA (siRNA) Market Size (2020-2031)
10.2 Middle East & Africa Small Interfering RNA (siRNA) Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Small Interfering RNA (siRNA) Market Size by Country (2020-2025)
10.4 Middle East & Africa Small Interfering RNA (siRNA) Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Agilent Technologies
11.1.1 Agilent Technologies Company Details
11.1.2 Agilent Technologies Business Overview
11.1.3 Agilent Technologies Small Interfering RNA (siRNA) Introduction
11.1.4 Agilent Technologies Revenue in Small Interfering RNA (siRNA) Business (2020-2025)
11.1.5 Agilent Technologies Recent Development
11.2 Merck KGaA
11.2.1 Merck KGaA Company Details
11.2.2 Merck KGaA Business Overview
11.2.3 Merck KGaA Small Interfering RNA (siRNA) Introduction
11.2.4 Merck KGaA Revenue in Small Interfering RNA (siRNA) Business (2020-2025)
11.2.5 Merck KGaA Recent Development
11.3 QIAGEN (Exiqon)
11.3.1 QIAGEN (Exiqon) Company Details
11.3.2 QIAGEN (Exiqon) Business Overview
11.3.3 QIAGEN (Exiqon) Small Interfering RNA (siRNA) Introduction
11.3.4 QIAGEN (Exiqon) Revenue in Small Interfering RNA (siRNA) Business (2020-2025)
11.3.5 QIAGEN (Exiqon) Recent Development
11.4 NanoString Technologies, Inc.
11.4.1 NanoString Technologies, Inc. Company Details
11.4.2 NanoString Technologies, Inc. Business Overview
11.4.3 NanoString Technologies, Inc. Small Interfering RNA (siRNA) Introduction
11.4.4 NanoString Technologies, Inc. Revenue in Small Interfering RNA (siRNA) Business (2020-2025)
11.4.5 NanoString Technologies, Inc. Recent Development
11.5 Dharmacon (Horizon Discovery Group)
11.5.1 Dharmacon (Horizon Discovery Group) Company Details
11.5.2 Dharmacon (Horizon Discovery Group) Business Overview
11.5.3 Dharmacon (Horizon Discovery Group) Small Interfering RNA (siRNA) Introduction
11.5.4 Dharmacon (Horizon Discovery Group) Revenue in Small Interfering RNA (siRNA) Business (2020-2025)
11.5.5 Dharmacon (Horizon Discovery Group) Recent Development
11.6 Synlogic
11.6.1 Synlogic Company Details
11.6.2 Synlogic Business Overview
11.6.3 Synlogic Small Interfering RNA (siRNA) Introduction
11.6.4 Synlogic Revenue in Small Interfering RNA (siRNA) Business (2020-2025)
11.6.5 Synlogic Recent Development
11.7 GeneCopoeia, Inc.
11.7.1 GeneCopoeia, Inc. Company Details
11.7.2 GeneCopoeia, Inc. Business Overview
11.7.3 GeneCopoeia, Inc. Small Interfering RNA (siRNA) Introduction
11.7.4 GeneCopoeia, Inc. Revenue in Small Interfering RNA (siRNA) Business (2020-2025)
11.7.5 GeneCopoeia, Inc. Recent Development
11.8 New England Biolabs
11.8.1 New England Biolabs Company Details
11.8.2 New England Biolabs Business Overview
11.8.3 New England Biolabs Small Interfering RNA (siRNA) Introduction
11.8.4 New England Biolabs Revenue in Small Interfering RNA (siRNA) Business (2020-2025)
11.8.5 New England Biolabs Recent Development
11.9 Quantabio
11.9.1 Quantabio Company Details
11.9.2 Quantabio Business Overview
11.9.3 Quantabio Small Interfering RNA (siRNA) Introduction
11.9.4 Quantabio Revenue in Small Interfering RNA (siRNA) Business (2020-2025)
11.9.5 Quantabio Recent Development
11.10 NanoString Technologies, Inc.
11.10.1 NanoString Technologies, Inc. Company Details
11.10.2 NanoString Technologies, Inc. Business Overview
11.10.3 NanoString Technologies, Inc. Small Interfering RNA (siRNA) Introduction
11.10.4 NanoString Technologies, Inc. Revenue in Small Interfering RNA (siRNA) Business (2020-2025)
11.10.5 NanoString Technologies, Inc. Recent Development
11.11 BioGenex
11.11.1 BioGenex Company Details
11.11.2 BioGenex Business Overview
11.11.3 BioGenex Small Interfering RNA (siRNA) Introduction
11.11.4 BioGenex Revenue in Small Interfering RNA (siRNA) Business (2020-2025)
11.11.5 BioGenex Recent Development
11.12 SeqMatic LLC
11.12.1 SeqMatic LLC Company Details
11.12.2 SeqMatic LLC Business Overview
11.12.3 SeqMatic LLC Small Interfering RNA (siRNA) Introduction
11.12.4 SeqMatic LLC Revenue in Small Interfering RNA (siRNA) Business (2020-2025)
11.12.5 SeqMatic LLC Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Small Interfering RNA (siRNA) Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 General Chemical Synthesis of siRNA
1.2.3 Sterol Modified Chemical Synthesis of siRNA
1.3 Market by Application
1.3.1 Global Small Interfering RNA (siRNA) Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Cancer
1.3.3 Infectious Diseases
1.3.4 Immunological Disorder
1.3.5 Cardiovascular Disease
1.3.6 Neurological Disease
1.3.7 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Small Interfering RNA (siRNA) Market Perspective (2020-2031)
2.2 Global Small Interfering RNA (siRNA) Growth Trends by Region
2.2.1 Global Small Interfering RNA (siRNA) Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Small Interfering RNA (siRNA) Historic Market Size by Region (2020-2025)
2.2.3 Small Interfering RNA (siRNA) Forecasted Market Size by Region (2026-2031)
2.3 Small Interfering RNA (siRNA) Market Dynamics
2.3.1 Small Interfering RNA (siRNA) Industry Trends
2.3.2 Small Interfering RNA (siRNA) Market Drivers
2.3.3 Small Interfering RNA (siRNA) Market Challenges
2.3.4 Small Interfering RNA (siRNA) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Small Interfering RNA (siRNA) Players by Revenue
3.1.1 Global Top Small Interfering RNA (siRNA) Players by Revenue (2020-2025)
3.1.2 Global Small Interfering RNA (siRNA) Revenue Market Share by Players (2020-2025)
3.2 Global Small Interfering RNA (siRNA) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Small Interfering RNA (siRNA) Revenue
3.4 Global Small Interfering RNA (siRNA) Market Concentration Ratio
3.4.1 Global Small Interfering RNA (siRNA) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Small Interfering RNA (siRNA) Revenue in 2024
3.5 Global Key Players of Small Interfering RNA (siRNA) Head office and Area Served
3.6 Global Key Players of Small Interfering RNA (siRNA), Product and Application
3.7 Global Key Players of Small Interfering RNA (siRNA), Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Small Interfering RNA (siRNA) Breakdown Data by Type
4.1 Global Small Interfering RNA (siRNA) Historic Market Size by Type (2020-2025)
4.2 Global Small Interfering RNA (siRNA) Forecasted Market Size by Type (2026-2031)
5 Small Interfering RNA (siRNA) Breakdown Data by Application
5.1 Global Small Interfering RNA (siRNA) Historic Market Size by Application (2020-2025)
5.2 Global Small Interfering RNA (siRNA) Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Small Interfering RNA (siRNA) Market Size (2020-2031)
6.2 North America Small Interfering RNA (siRNA) Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Small Interfering RNA (siRNA) Market Size by Country (2020-2025)
6.4 North America Small Interfering RNA (siRNA) Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Small Interfering RNA (siRNA) Market Size (2020-2031)
7.2 Europe Small Interfering RNA (siRNA) Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Small Interfering RNA (siRNA) Market Size by Country (2020-2025)
7.4 Europe Small Interfering RNA (siRNA) Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Small Interfering RNA (siRNA) Market Size (2020-2031)
8.2 Asia-Pacific Small Interfering RNA (siRNA) Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Small Interfering RNA (siRNA) Market Size by Region (2020-2025)
8.4 Asia-Pacific Small Interfering RNA (siRNA) Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Small Interfering RNA (siRNA) Market Size (2020-2031)
9.2 Latin America Small Interfering RNA (siRNA) Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Small Interfering RNA (siRNA) Market Size by Country (2020-2025)
9.4 Latin America Small Interfering RNA (siRNA) Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Small Interfering RNA (siRNA) Market Size (2020-2031)
10.2 Middle East & Africa Small Interfering RNA (siRNA) Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Small Interfering RNA (siRNA) Market Size by Country (2020-2025)
10.4 Middle East & Africa Small Interfering RNA (siRNA) Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Agilent Technologies
11.1.1 Agilent Technologies Company Details
11.1.2 Agilent Technologies Business Overview
11.1.3 Agilent Technologies Small Interfering RNA (siRNA) Introduction
11.1.4 Agilent Technologies Revenue in Small Interfering RNA (siRNA) Business (2020-2025)
11.1.5 Agilent Technologies Recent Development
11.2 Merck KGaA
11.2.1 Merck KGaA Company Details
11.2.2 Merck KGaA Business Overview
11.2.3 Merck KGaA Small Interfering RNA (siRNA) Introduction
11.2.4 Merck KGaA Revenue in Small Interfering RNA (siRNA) Business (2020-2025)
11.2.5 Merck KGaA Recent Development
11.3 QIAGEN (Exiqon)
11.3.1 QIAGEN (Exiqon) Company Details
11.3.2 QIAGEN (Exiqon) Business Overview
11.3.3 QIAGEN (Exiqon) Small Interfering RNA (siRNA) Introduction
11.3.4 QIAGEN (Exiqon) Revenue in Small Interfering RNA (siRNA) Business (2020-2025)
11.3.5 QIAGEN (Exiqon) Recent Development
11.4 NanoString Technologies, Inc.
11.4.1 NanoString Technologies, Inc. Company Details
11.4.2 NanoString Technologies, Inc. Business Overview
11.4.3 NanoString Technologies, Inc. Small Interfering RNA (siRNA) Introduction
11.4.4 NanoString Technologies, Inc. Revenue in Small Interfering RNA (siRNA) Business (2020-2025)
11.4.5 NanoString Technologies, Inc. Recent Development
11.5 Dharmacon (Horizon Discovery Group)
11.5.1 Dharmacon (Horizon Discovery Group) Company Details
11.5.2 Dharmacon (Horizon Discovery Group) Business Overview
11.5.3 Dharmacon (Horizon Discovery Group) Small Interfering RNA (siRNA) Introduction
11.5.4 Dharmacon (Horizon Discovery Group) Revenue in Small Interfering RNA (siRNA) Business (2020-2025)
11.5.5 Dharmacon (Horizon Discovery Group) Recent Development
11.6 Synlogic
11.6.1 Synlogic Company Details
11.6.2 Synlogic Business Overview
11.6.3 Synlogic Small Interfering RNA (siRNA) Introduction
11.6.4 Synlogic Revenue in Small Interfering RNA (siRNA) Business (2020-2025)
11.6.5 Synlogic Recent Development
11.7 GeneCopoeia, Inc.
11.7.1 GeneCopoeia, Inc. Company Details
11.7.2 GeneCopoeia, Inc. Business Overview
11.7.3 GeneCopoeia, Inc. Small Interfering RNA (siRNA) Introduction
11.7.4 GeneCopoeia, Inc. Revenue in Small Interfering RNA (siRNA) Business (2020-2025)
11.7.5 GeneCopoeia, Inc. Recent Development
11.8 New England Biolabs
11.8.1 New England Biolabs Company Details
11.8.2 New England Biolabs Business Overview
11.8.3 New England Biolabs Small Interfering RNA (siRNA) Introduction
11.8.4 New England Biolabs Revenue in Small Interfering RNA (siRNA) Business (2020-2025)
11.8.5 New England Biolabs Recent Development
11.9 Quantabio
11.9.1 Quantabio Company Details
11.9.2 Quantabio Business Overview
11.9.3 Quantabio Small Interfering RNA (siRNA) Introduction
11.9.4 Quantabio Revenue in Small Interfering RNA (siRNA) Business (2020-2025)
11.9.5 Quantabio Recent Development
11.10 NanoString Technologies, Inc.
11.10.1 NanoString Technologies, Inc. Company Details
11.10.2 NanoString Technologies, Inc. Business Overview
11.10.3 NanoString Technologies, Inc. Small Interfering RNA (siRNA) Introduction
11.10.4 NanoString Technologies, Inc. Revenue in Small Interfering RNA (siRNA) Business (2020-2025)
11.10.5 NanoString Technologies, Inc. Recent Development
11.11 BioGenex
11.11.1 BioGenex Company Details
11.11.2 BioGenex Business Overview
11.11.3 BioGenex Small Interfering RNA (siRNA) Introduction
11.11.4 BioGenex Revenue in Small Interfering RNA (siRNA) Business (2020-2025)
11.11.5 BioGenex Recent Development
11.12 SeqMatic LLC
11.12.1 SeqMatic LLC Company Details
11.12.2 SeqMatic LLC Business Overview
11.12.3 SeqMatic LLC Small Interfering RNA (siRNA) Introduction
11.12.4 SeqMatic LLC Revenue in Small Interfering RNA (siRNA) Business (2020-2025)
11.12.5 SeqMatic LLC Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Small Interfering RNA (siRNA) Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of General Chemical Synthesis of siRNA
Table 3. Key Players of Sterol Modified Chemical Synthesis of siRNA
Table 4. Global Small Interfering RNA (siRNA) Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Small Interfering RNA (siRNA) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Small Interfering RNA (siRNA) Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Small Interfering RNA (siRNA) Market Share by Region (2020-2025)
Table 8. Global Small Interfering RNA (siRNA) Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Small Interfering RNA (siRNA) Market Share by Region (2026-2031)
Table 10. Small Interfering RNA (siRNA) Market Trends
Table 11. Small Interfering RNA (siRNA) Market Drivers
Table 12. Small Interfering RNA (siRNA) Market Challenges
Table 13. Small Interfering RNA (siRNA) Market Restraints
Table 14. Global Small Interfering RNA (siRNA) Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Small Interfering RNA (siRNA) Market Share by Players (2020-2025)
Table 16. Global Top Small Interfering RNA (siRNA) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Small Interfering RNA (siRNA) as of 2024)
Table 17. Ranking of Global Top Small Interfering RNA (siRNA) Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Small Interfering RNA (siRNA) Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Small Interfering RNA (siRNA), Headquarters and Area Served
Table 20. Global Key Players of Small Interfering RNA (siRNA), Product and Application
Table 21. Global Key Players of Small Interfering RNA (siRNA), Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Small Interfering RNA (siRNA) Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Small Interfering RNA (siRNA) Revenue Market Share by Type (2020-2025)
Table 25. Global Small Interfering RNA (siRNA) Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Small Interfering RNA (siRNA) Revenue Market Share by Type (2026-2031)
Table 27. Global Small Interfering RNA (siRNA) Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Small Interfering RNA (siRNA) Revenue Market Share by Application (2020-2025)
Table 29. Global Small Interfering RNA (siRNA) Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Small Interfering RNA (siRNA) Revenue Market Share by Application (2026-2031)
Table 31. North America Small Interfering RNA (siRNA) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Small Interfering RNA (siRNA) Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Small Interfering RNA (siRNA) Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Small Interfering RNA (siRNA) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Small Interfering RNA (siRNA) Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Small Interfering RNA (siRNA) Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Small Interfering RNA (siRNA) Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Small Interfering RNA (siRNA) Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Small Interfering RNA (siRNA) Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Small Interfering RNA (siRNA) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Small Interfering RNA (siRNA) Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Small Interfering RNA (siRNA) Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Small Interfering RNA (siRNA) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Small Interfering RNA (siRNA) Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Small Interfering RNA (siRNA) Market Size by Country (2026-2031) & (US$ Million)
Table 46. Agilent Technologies Company Details
Table 47. Agilent Technologies Business Overview
Table 48. Agilent Technologies Small Interfering RNA (siRNA) Product
Table 49. Agilent Technologies Revenue in Small Interfering RNA (siRNA) Business (2020-2025) & (US$ Million)
Table 50. Agilent Technologies Recent Development
Table 51. Merck KGaA Company Details
Table 52. Merck KGaA Business Overview
Table 53. Merck KGaA Small Interfering RNA (siRNA) Product
Table 54. Merck KGaA Revenue in Small Interfering RNA (siRNA) Business (2020-2025) & (US$ Million)
Table 55. Merck KGaA Recent Development
Table 56. QIAGEN (Exiqon) Company Details
Table 57. QIAGEN (Exiqon) Business Overview
Table 58. QIAGEN (Exiqon) Small Interfering RNA (siRNA) Product
Table 59. QIAGEN (Exiqon) Revenue in Small Interfering RNA (siRNA) Business (2020-2025) & (US$ Million)
Table 60. QIAGEN (Exiqon) Recent Development
Table 61. NanoString Technologies, Inc. Company Details
Table 62. NanoString Technologies, Inc. Business Overview
Table 63. NanoString Technologies, Inc. Small Interfering RNA (siRNA) Product
Table 64. NanoString Technologies, Inc. Revenue in Small Interfering RNA (siRNA) Business (2020-2025) & (US$ Million)
Table 65. NanoString Technologies, Inc. Recent Development
Table 66. Dharmacon (Horizon Discovery Group) Company Details
Table 67. Dharmacon (Horizon Discovery Group) Business Overview
Table 68. Dharmacon (Horizon Discovery Group) Small Interfering RNA (siRNA) Product
Table 69. Dharmacon (Horizon Discovery Group) Revenue in Small Interfering RNA (siRNA) Business (2020-2025) & (US$ Million)
Table 70. Dharmacon (Horizon Discovery Group) Recent Development
Table 71. Synlogic Company Details
Table 72. Synlogic Business Overview
Table 73. Synlogic Small Interfering RNA (siRNA) Product
Table 74. Synlogic Revenue in Small Interfering RNA (siRNA) Business (2020-2025) & (US$ Million)
Table 75. Synlogic Recent Development
Table 76. GeneCopoeia, Inc. Company Details
Table 77. GeneCopoeia, Inc. Business Overview
Table 78. GeneCopoeia, Inc. Small Interfering RNA (siRNA) Product
Table 79. GeneCopoeia, Inc. Revenue in Small Interfering RNA (siRNA) Business (2020-2025) & (US$ Million)
Table 80. GeneCopoeia, Inc. Recent Development
Table 81. New England Biolabs Company Details
Table 82. New England Biolabs Business Overview
Table 83. New England Biolabs Small Interfering RNA (siRNA) Product
Table 84. New England Biolabs Revenue in Small Interfering RNA (siRNA) Business (2020-2025) & (US$ Million)
Table 85. New England Biolabs Recent Development
Table 86. Quantabio Company Details
Table 87. Quantabio Business Overview
Table 88. Quantabio Small Interfering RNA (siRNA) Product
Table 89. Quantabio Revenue in Small Interfering RNA (siRNA) Business (2020-2025) & (US$ Million)
Table 90. Quantabio Recent Development
Table 91. NanoString Technologies, Inc. Company Details
Table 92. NanoString Technologies, Inc. Business Overview
Table 93. NanoString Technologies, Inc. Small Interfering RNA (siRNA) Product
Table 94. NanoString Technologies, Inc. Revenue in Small Interfering RNA (siRNA) Business (2020-2025) & (US$ Million)
Table 95. NanoString Technologies, Inc. Recent Development
Table 96. BioGenex Company Details
Table 97. BioGenex Business Overview
Table 98. BioGenex Small Interfering RNA (siRNA) Product
Table 99. BioGenex Revenue in Small Interfering RNA (siRNA) Business (2020-2025) & (US$ Million)
Table 100. BioGenex Recent Development
Table 101. SeqMatic LLC Company Details
Table 102. SeqMatic LLC Business Overview
Table 103. SeqMatic LLC Small Interfering RNA (siRNA) Product
Table 104. SeqMatic LLC Revenue in Small Interfering RNA (siRNA) Business (2020-2025) & (US$ Million)
Table 105. SeqMatic LLC Recent Development
Table 106. Research Programs/Design for This Report
Table 107. Key Data Information from Secondary Sources
Table 108. Key Data Information from Primary Sources
Table 109. Authors List of This Report
List of Figures
Figure 1. Small Interfering RNA (siRNA) Picture
Figure 2. Global Small Interfering RNA (siRNA) Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Small Interfering RNA (siRNA) Market Share by Type: 2024 VS 2031
Figure 4. General Chemical Synthesis of siRNA Features
Figure 5. Sterol Modified Chemical Synthesis of siRNA Features
Figure 6. Global Small Interfering RNA (siRNA) Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Small Interfering RNA (siRNA) Market Share by Application: 2024 VS 2031
Figure 8. Cancer Case Studies
Figure 9. Infectious Diseases Case Studies
Figure 10. Immunological Disorder Case Studies
Figure 11. Cardiovascular Disease Case Studies
Figure 12. Neurological Disease Case Studies
Figure 13. Others Case Studies
Figure 14. Small Interfering RNA (siRNA) Report Years Considered
Figure 15. Global Small Interfering RNA (siRNA) Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 16. Global Small Interfering RNA (siRNA) Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 17. Global Small Interfering RNA (siRNA) Market Share by Region: 2024 VS 2031
Figure 18. Global Small Interfering RNA (siRNA) Market Share by Players in 2024
Figure 19. Global Top Small Interfering RNA (siRNA) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Small Interfering RNA (siRNA) as of 2024)
Figure 20. The Top 10 and 5 Players Market Share by Small Interfering RNA (siRNA) Revenue in 2024
Figure 21. North America Small Interfering RNA (siRNA) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. North America Small Interfering RNA (siRNA) Market Share by Country (2020-2031)
Figure 23. United States Small Interfering RNA (siRNA) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Canada Small Interfering RNA (siRNA) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Small Interfering RNA (siRNA) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Europe Small Interfering RNA (siRNA) Market Share by Country (2020-2031)
Figure 27. Germany Small Interfering RNA (siRNA) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. France Small Interfering RNA (siRNA) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. U.K. Small Interfering RNA (siRNA) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Italy Small Interfering RNA (siRNA) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Russia Small Interfering RNA (siRNA) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Nordic Countries Small Interfering RNA (siRNA) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Small Interfering RNA (siRNA) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Asia-Pacific Small Interfering RNA (siRNA) Market Share by Region (2020-2031)
Figure 35. China Small Interfering RNA (siRNA) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Japan Small Interfering RNA (siRNA) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. South Korea Small Interfering RNA (siRNA) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Southeast Asia Small Interfering RNA (siRNA) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. India Small Interfering RNA (siRNA) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Australia Small Interfering RNA (siRNA) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Small Interfering RNA (siRNA) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Latin America Small Interfering RNA (siRNA) Market Share by Country (2020-2031)
Figure 43. Mexico Small Interfering RNA (siRNA) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Brazil Small Interfering RNA (siRNA) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Small Interfering RNA (siRNA) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Middle East & Africa Small Interfering RNA (siRNA) Market Share by Country (2020-2031)
Figure 47. Turkey Small Interfering RNA (siRNA) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Saudi Arabia Small Interfering RNA (siRNA) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. UAE Small Interfering RNA (siRNA) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. Agilent Technologies Revenue Growth Rate in Small Interfering RNA (siRNA) Business (2020-2025)
Figure 51. Merck KGaA Revenue Growth Rate in Small Interfering RNA (siRNA) Business (2020-2025)
Figure 52. QIAGEN (Exiqon) Revenue Growth Rate in Small Interfering RNA (siRNA) Business (2020-2025)
Figure 53. NanoString Technologies, Inc. Revenue Growth Rate in Small Interfering RNA (siRNA) Business (2020-2025)
Figure 54. Dharmacon (Horizon Discovery Group) Revenue Growth Rate in Small Interfering RNA (siRNA) Business (2020-2025)
Figure 55. Synlogic Revenue Growth Rate in Small Interfering RNA (siRNA) Business (2020-2025)
Figure 56. GeneCopoeia, Inc. Revenue Growth Rate in Small Interfering RNA (siRNA) Business (2020-2025)
Figure 57. New England Biolabs Revenue Growth Rate in Small Interfering RNA (siRNA) Business (2020-2025)
Figure 58. Quantabio Revenue Growth Rate in Small Interfering RNA (siRNA) Business (2020-2025)
Figure 59. NanoString Technologies, Inc. Revenue Growth Rate in Small Interfering RNA (siRNA) Business (2020-2025)
Figure 60. BioGenex Revenue Growth Rate in Small Interfering RNA (siRNA) Business (2020-2025)
Figure 61. SeqMatic LLC Revenue Growth Rate in Small Interfering RNA (siRNA) Business (2020-2025)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Table 1. Global Small Interfering RNA (siRNA) Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of General Chemical Synthesis of siRNA
Table 3. Key Players of Sterol Modified Chemical Synthesis of siRNA
Table 4. Global Small Interfering RNA (siRNA) Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Small Interfering RNA (siRNA) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Small Interfering RNA (siRNA) Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Small Interfering RNA (siRNA) Market Share by Region (2020-2025)
Table 8. Global Small Interfering RNA (siRNA) Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Small Interfering RNA (siRNA) Market Share by Region (2026-2031)
Table 10. Small Interfering RNA (siRNA) Market Trends
Table 11. Small Interfering RNA (siRNA) Market Drivers
Table 12. Small Interfering RNA (siRNA) Market Challenges
Table 13. Small Interfering RNA (siRNA) Market Restraints
Table 14. Global Small Interfering RNA (siRNA) Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Small Interfering RNA (siRNA) Market Share by Players (2020-2025)
Table 16. Global Top Small Interfering RNA (siRNA) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Small Interfering RNA (siRNA) as of 2024)
Table 17. Ranking of Global Top Small Interfering RNA (siRNA) Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Small Interfering RNA (siRNA) Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Small Interfering RNA (siRNA), Headquarters and Area Served
Table 20. Global Key Players of Small Interfering RNA (siRNA), Product and Application
Table 21. Global Key Players of Small Interfering RNA (siRNA), Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Small Interfering RNA (siRNA) Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Small Interfering RNA (siRNA) Revenue Market Share by Type (2020-2025)
Table 25. Global Small Interfering RNA (siRNA) Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Small Interfering RNA (siRNA) Revenue Market Share by Type (2026-2031)
Table 27. Global Small Interfering RNA (siRNA) Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Small Interfering RNA (siRNA) Revenue Market Share by Application (2020-2025)
Table 29. Global Small Interfering RNA (siRNA) Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Small Interfering RNA (siRNA) Revenue Market Share by Application (2026-2031)
Table 31. North America Small Interfering RNA (siRNA) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Small Interfering RNA (siRNA) Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Small Interfering RNA (siRNA) Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Small Interfering RNA (siRNA) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Small Interfering RNA (siRNA) Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Small Interfering RNA (siRNA) Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Small Interfering RNA (siRNA) Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Small Interfering RNA (siRNA) Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Small Interfering RNA (siRNA) Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Small Interfering RNA (siRNA) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Small Interfering RNA (siRNA) Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Small Interfering RNA (siRNA) Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Small Interfering RNA (siRNA) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Small Interfering RNA (siRNA) Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Small Interfering RNA (siRNA) Market Size by Country (2026-2031) & (US$ Million)
Table 46. Agilent Technologies Company Details
Table 47. Agilent Technologies Business Overview
Table 48. Agilent Technologies Small Interfering RNA (siRNA) Product
Table 49. Agilent Technologies Revenue in Small Interfering RNA (siRNA) Business (2020-2025) & (US$ Million)
Table 50. Agilent Technologies Recent Development
Table 51. Merck KGaA Company Details
Table 52. Merck KGaA Business Overview
Table 53. Merck KGaA Small Interfering RNA (siRNA) Product
Table 54. Merck KGaA Revenue in Small Interfering RNA (siRNA) Business (2020-2025) & (US$ Million)
Table 55. Merck KGaA Recent Development
Table 56. QIAGEN (Exiqon) Company Details
Table 57. QIAGEN (Exiqon) Business Overview
Table 58. QIAGEN (Exiqon) Small Interfering RNA (siRNA) Product
Table 59. QIAGEN (Exiqon) Revenue in Small Interfering RNA (siRNA) Business (2020-2025) & (US$ Million)
Table 60. QIAGEN (Exiqon) Recent Development
Table 61. NanoString Technologies, Inc. Company Details
Table 62. NanoString Technologies, Inc. Business Overview
Table 63. NanoString Technologies, Inc. Small Interfering RNA (siRNA) Product
Table 64. NanoString Technologies, Inc. Revenue in Small Interfering RNA (siRNA) Business (2020-2025) & (US$ Million)
Table 65. NanoString Technologies, Inc. Recent Development
Table 66. Dharmacon (Horizon Discovery Group) Company Details
Table 67. Dharmacon (Horizon Discovery Group) Business Overview
Table 68. Dharmacon (Horizon Discovery Group) Small Interfering RNA (siRNA) Product
Table 69. Dharmacon (Horizon Discovery Group) Revenue in Small Interfering RNA (siRNA) Business (2020-2025) & (US$ Million)
Table 70. Dharmacon (Horizon Discovery Group) Recent Development
Table 71. Synlogic Company Details
Table 72. Synlogic Business Overview
Table 73. Synlogic Small Interfering RNA (siRNA) Product
Table 74. Synlogic Revenue in Small Interfering RNA (siRNA) Business (2020-2025) & (US$ Million)
Table 75. Synlogic Recent Development
Table 76. GeneCopoeia, Inc. Company Details
Table 77. GeneCopoeia, Inc. Business Overview
Table 78. GeneCopoeia, Inc. Small Interfering RNA (siRNA) Product
Table 79. GeneCopoeia, Inc. Revenue in Small Interfering RNA (siRNA) Business (2020-2025) & (US$ Million)
Table 80. GeneCopoeia, Inc. Recent Development
Table 81. New England Biolabs Company Details
Table 82. New England Biolabs Business Overview
Table 83. New England Biolabs Small Interfering RNA (siRNA) Product
Table 84. New England Biolabs Revenue in Small Interfering RNA (siRNA) Business (2020-2025) & (US$ Million)
Table 85. New England Biolabs Recent Development
Table 86. Quantabio Company Details
Table 87. Quantabio Business Overview
Table 88. Quantabio Small Interfering RNA (siRNA) Product
Table 89. Quantabio Revenue in Small Interfering RNA (siRNA) Business (2020-2025) & (US$ Million)
Table 90. Quantabio Recent Development
Table 91. NanoString Technologies, Inc. Company Details
Table 92. NanoString Technologies, Inc. Business Overview
Table 93. NanoString Technologies, Inc. Small Interfering RNA (siRNA) Product
Table 94. NanoString Technologies, Inc. Revenue in Small Interfering RNA (siRNA) Business (2020-2025) & (US$ Million)
Table 95. NanoString Technologies, Inc. Recent Development
Table 96. BioGenex Company Details
Table 97. BioGenex Business Overview
Table 98. BioGenex Small Interfering RNA (siRNA) Product
Table 99. BioGenex Revenue in Small Interfering RNA (siRNA) Business (2020-2025) & (US$ Million)
Table 100. BioGenex Recent Development
Table 101. SeqMatic LLC Company Details
Table 102. SeqMatic LLC Business Overview
Table 103. SeqMatic LLC Small Interfering RNA (siRNA) Product
Table 104. SeqMatic LLC Revenue in Small Interfering RNA (siRNA) Business (2020-2025) & (US$ Million)
Table 105. SeqMatic LLC Recent Development
Table 106. Research Programs/Design for This Report
Table 107. Key Data Information from Secondary Sources
Table 108. Key Data Information from Primary Sources
Table 109. Authors List of This Report
List of Figures
Figure 1. Small Interfering RNA (siRNA) Picture
Figure 2. Global Small Interfering RNA (siRNA) Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Small Interfering RNA (siRNA) Market Share by Type: 2024 VS 2031
Figure 4. General Chemical Synthesis of siRNA Features
Figure 5. Sterol Modified Chemical Synthesis of siRNA Features
Figure 6. Global Small Interfering RNA (siRNA) Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Small Interfering RNA (siRNA) Market Share by Application: 2024 VS 2031
Figure 8. Cancer Case Studies
Figure 9. Infectious Diseases Case Studies
Figure 10. Immunological Disorder Case Studies
Figure 11. Cardiovascular Disease Case Studies
Figure 12. Neurological Disease Case Studies
Figure 13. Others Case Studies
Figure 14. Small Interfering RNA (siRNA) Report Years Considered
Figure 15. Global Small Interfering RNA (siRNA) Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 16. Global Small Interfering RNA (siRNA) Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 17. Global Small Interfering RNA (siRNA) Market Share by Region: 2024 VS 2031
Figure 18. Global Small Interfering RNA (siRNA) Market Share by Players in 2024
Figure 19. Global Top Small Interfering RNA (siRNA) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Small Interfering RNA (siRNA) as of 2024)
Figure 20. The Top 10 and 5 Players Market Share by Small Interfering RNA (siRNA) Revenue in 2024
Figure 21. North America Small Interfering RNA (siRNA) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. North America Small Interfering RNA (siRNA) Market Share by Country (2020-2031)
Figure 23. United States Small Interfering RNA (siRNA) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Canada Small Interfering RNA (siRNA) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Small Interfering RNA (siRNA) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Europe Small Interfering RNA (siRNA) Market Share by Country (2020-2031)
Figure 27. Germany Small Interfering RNA (siRNA) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. France Small Interfering RNA (siRNA) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. U.K. Small Interfering RNA (siRNA) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Italy Small Interfering RNA (siRNA) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Russia Small Interfering RNA (siRNA) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Nordic Countries Small Interfering RNA (siRNA) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Small Interfering RNA (siRNA) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Asia-Pacific Small Interfering RNA (siRNA) Market Share by Region (2020-2031)
Figure 35. China Small Interfering RNA (siRNA) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Japan Small Interfering RNA (siRNA) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. South Korea Small Interfering RNA (siRNA) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Southeast Asia Small Interfering RNA (siRNA) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. India Small Interfering RNA (siRNA) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Australia Small Interfering RNA (siRNA) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Small Interfering RNA (siRNA) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Latin America Small Interfering RNA (siRNA) Market Share by Country (2020-2031)
Figure 43. Mexico Small Interfering RNA (siRNA) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Brazil Small Interfering RNA (siRNA) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Small Interfering RNA (siRNA) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Middle East & Africa Small Interfering RNA (siRNA) Market Share by Country (2020-2031)
Figure 47. Turkey Small Interfering RNA (siRNA) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Saudi Arabia Small Interfering RNA (siRNA) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. UAE Small Interfering RNA (siRNA) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. Agilent Technologies Revenue Growth Rate in Small Interfering RNA (siRNA) Business (2020-2025)
Figure 51. Merck KGaA Revenue Growth Rate in Small Interfering RNA (siRNA) Business (2020-2025)
Figure 52. QIAGEN (Exiqon) Revenue Growth Rate in Small Interfering RNA (siRNA) Business (2020-2025)
Figure 53. NanoString Technologies, Inc. Revenue Growth Rate in Small Interfering RNA (siRNA) Business (2020-2025)
Figure 54. Dharmacon (Horizon Discovery Group) Revenue Growth Rate in Small Interfering RNA (siRNA) Business (2020-2025)
Figure 55. Synlogic Revenue Growth Rate in Small Interfering RNA (siRNA) Business (2020-2025)
Figure 56. GeneCopoeia, Inc. Revenue Growth Rate in Small Interfering RNA (siRNA) Business (2020-2025)
Figure 57. New England Biolabs Revenue Growth Rate in Small Interfering RNA (siRNA) Business (2020-2025)
Figure 58. Quantabio Revenue Growth Rate in Small Interfering RNA (siRNA) Business (2020-2025)
Figure 59. NanoString Technologies, Inc. Revenue Growth Rate in Small Interfering RNA (siRNA) Business (2020-2025)
Figure 60. BioGenex Revenue Growth Rate in Small Interfering RNA (siRNA) Business (2020-2025)
Figure 61. SeqMatic LLC Revenue Growth Rate in Small Interfering RNA (siRNA) Business (2020-2025)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Electrolytes for Lithium-Ion Batteries Market Research Report 2025
Jul 14, 25
Global Vanadium Products Market Research Report 2025
Jul 14, 25
Global High-purity Vanadium Oxide Market Research Report 2025
Jul 14, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232